Content about Mind

February 25, 2013
Dart and science

“The only real valuable thing is intuition,” said Albert Einstein. Within the consumer healthcare industry, nowhere is that more true than in the realm of brand management.

“The only real valuable thing is intuition,” said Albert Einstein. Within the consumer healthcare industry, nowhere is that more true than in the realm of brand management.

Ironically, Einstein also said “if we knew what it was we were doing, it would not be called research, would it?”

May 15, 2013
Program launched to raise awareness of depression among employers

According to a study published 10 years ago, depression costs $44 billion per year in lost productivity, but a new program is designed to raise awareness about depression in the workforce and its effects on productivity.

CANTON, Ohio — According to a study published 10 years ago, depression costs $44 billion per year in lost productivity, but a new program is designed to raise awareness about depression in the workforce and its effects on productivity.

May 2, 2013
More than 80% of mothers regularly experience pain, survey finds

The vast majority of mothers experience pain throughout their bodies, according to a new survey.

STERLING, Ill. — The vast majority of mothers experience pain throughout their bodies, according to a new survey.

The survey, commissioned by electric massager maker Wahl Clipper Corp. and conducted by Harris Interactive, found that 84% of mothers experience pain. This includes 80% who experience lower back pain, 76% with shoulder and neck pain, 70% with upper back pain and 65% with joint pain. The survey included 2,000 men and women, including 300 mothers with children younger than 18, who were asked about their pain and how they cope with it.

April 9, 2013
Americans consider addiction a greater problem than chronic pain, poll shows

A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

ALEXANDRIA, Va. — A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

March 18, 2013
Galena buys rights to cancer-pain drug from Orexo

Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.

LAKE OSWEGO, Ore. — Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.

Galena, which specializes in cancer-related drugs, said it acquired Abstral (fentanyl) sublingual tablets for sale and distribution in the United States from Orexo AB. Breakthrough cancer pain, or BTcP, affects between 40% to 80% of cancer patients, with reported episodes of four per day and a median duration of 30 minutes, according to Galena.

March 8, 2013
Switching off the pain

Omron recently charged analgesic aisles with a new pain relief option.

LAKE FOREST, Ill. — Omron recently charged analgesic aisles with a new pain relief option. Omron's Electro-Therapy Pain Relief unit is the only approved transcutaneous electrical nerve stimulation unit on the market and should be an adjunctive sale for chronic pain sufferers. The product could add a spark to nonmedicinal, external pain relief. Sales of heat and ice packs were relatively flat in 2012, with sales approaching $235 million.

January 7, 2013
Harvard Men's Health Watch recommends topical analgesics for acute joint pain

Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch.

BOSTON — Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch. 

"Topical pain relievers can be very helpful for the more superficial joints like the knees, ankles, feet, elbows and hands," stated Rosalyn Nguyen, a clinical instructor in physical medicine and rehabilitation at Harvard Medical School. "In those areas, the medication can penetrate closer to the joint."

November 15, 2012
OTC use on rise as self-care trend grows

Over-the-counter medications continue to gain in popularity among consumers, who — whether as a matter of cost savings or convenience — are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. 


Over-the-counter medications continue to gain in popularity among consumers, who — whether as a matter of cost savings or convenience — are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. 


To see more Patient Views, click here.

October 22, 2012
Pfizer buying ADHD drug maker

Pfizer is buying the maker of an attention deficit hyperactivity disorder drug for almost $700 million, Pfizer said Monday.

NEW YORK — Pfizer is buying the maker of an attention deficit hyperactivity disorder drug for almost $700 million, Pfizer said Monday.

The drug maker announced that it would buy privately owned NextWave Pharmaceuticals, which makes the extended-release ADHD drug Quillivant XR (methylphenidate hydrochloride), which the Food and Drug Administration approved last month. The drug is expected to appear in pharmacies in January 2013.

June 21, 2010
Nature Made promotes healthy minds with new supplement

More than two-thirds of Americans are worried about losing their minds, according to a recent...

NORTHRIDGE, Calif. More than two-thirds of Americans are worried about losing their minds, according to a recent poll released Monday. Or rather, 69% of Americans are concerned about maintaining a healthy, active and sharp mind, the survey -- conducted by Opinion Research Corp. on behalf of Pharmavite -- found. Almost as many respondents (68%) reported having experienced some form of cognitive decline.